NFE2L2 and Alzheimer disease: Following the induction of the scopolamine model of AD, we observed downregulation in the expression levels of Nrf2 (P < 0.001, Figure 7A) and upregulation of NF-κB (P < 0.001, Figure 7B) proteins in the hippocampal tissue of rats.